CARE Ratings Ltd
CARE Ratings Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on CARE Ratings Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Standalone Revenue from Operations for Q3FY25: Rs. Consolidated Q3FY25 Figures (Page 13): - Revenue from Operations: Rs.
From CARE Ratings Ltd's Q3 FY25 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Standalone Revenue from Operations for Q3FY25: Rs. 78.59 Crs, up 18% YoY (Page 2, 12)
- Standalone EBITDA for Q3FY25: Rs. 30.30 Crs, up 12% YoY (Page 2, 12)
- Standalone PAT for Q3FY25: Rs. 30.30 Crs, up 33% YoY (Page 2, 12)
- Consolidated Revenue from Operations for Q3FY25: Rs. 96.38 Crs, up 22% YoY (Page 2, 13)
- Consolidated EBITDA for Q3FY25: Rs. 30.43 Crs, up 30% YoY (Page 2, 13)
- Consolidated PAT for Q3FY25: Rs. 28.37 Crs, up 19% YoY (Page 2, 13)
2 more points management made on revenue & sales performance
Profitability & Margins
See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
CARE Ratings Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹131 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings Ltd's management said in earlier quarters
- Q1 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY20 earnings call →
- Q2 FY20 earnings call →
- Q1 FY20 earnings call →
- Q4 FY19 earnings call →
Others in Capital Markets this season
- ICRA Ltd (Q3 FY25)
Q3 FY2025 Revenue: ₹120.9 crore, up 5.5% YoY from ₹114.6 crore in Q3 FY2024 (Page 6). Key concall takeaways from ICRA Ltd's Q3 FY25 earnings call — and how it…
- IIFL Capital Services Ltd (Q3 FY25)
Revenue for Q3FY25: ₹6,464 million, up 11% YoY (Page 20) . Key concall takeaways from IIFL Capital Services Ltd's Q3 FY25 earnings call — and how it ranks…
- 360 ONE WAM Ltd (Q3 FY25)
Q3 FY25 Total Revenues: INR 678 Crs, up 45.4% YoY (Page 2) . Key concall takeaways from 360 ONE WAM Ltd's Q3 FY25 earnings call — and how it ranks against…
- Geojit Financial Services Ltd (Q3 FY25)
Market Capitalization:** ₹3,227 crore (as on 31-Dec-2024) . Key concall takeaways from Geojit Financial Services Ltd's Q3 FY25 earnings call — and how it ranks…
Frequently Asked Questions
What were CARE Ratings Ltd Q3 FY25 results?
Standalone Revenue from Operations for Q3FY25: Rs. Consolidated Q3FY25 Figures (Page 13): - Revenue from Operations: Rs.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Is CARE Ratings Ltd planning capital expenditure?
The provided investor presentation does not mention any details about capex, capacity expansion, new plants, or projects, including amounts, status, or timelines.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.